1-Hassanen,
O.,
Ghieda,
U.,
& Eltomey,
M.
A.
(2017).
Contrast enhanced MRI and Diffusion Weighted Imaging (DWI) in the evaluation of renal cell carcinoma and differentiation of its subtypes. The Egyptian Journal of Radiology and Nuclear Medicine.
2-Mytsyk,
Y.,
Dutka,
I.,
Borys,
Y.,
Komnatska,
I.,
Shatynska-Mytsyk,
I.,
Farooqi,
A.
A.,
...
& Kruzliak,
P.
(2017).
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis,
histologic subtyping,
and differentiation grade. International urology and nephrology, 49(2),
215-224.
3-Yamamoto,
A.,
Tamada,
T.,
Ito,
K.,
Sone,
T.,
Kanki,
A.,
Tanimoto,
D.,
& Noda,
Y.
(2017).
Differentiation of subtypes of renal cell carcinoma: dynamic contrast-enhanced magnetic resonance imaging versus diffusion-weighted magnetic resonance imaging. Clinical imaging, 41,
53-58.
4-Villavicencio,
C.
P.,
Mc Carthy,
R.
J.,
& Miller,
F.
H.
(2017).
Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors. Abdominal Radiology, 42(4),
1241-1249.